Dr. Moira Gunn speaks with Gregory Mitchell, a research biologist at the Scripps Institution of Oceanography, about the economics of algae, and why it forms to basis of most bio-fuel research.
What many Dell customers don't know is that the company is making a major effort in biotech, as Dr. Moira Gunn finds out when she speaks with Scott Jenkins, the director of the Dell's Healthcare & Life Sciences program.
Dr. Moira Gunn speaks with Dr. Gary Small, the director of the UCLA Memory & Aging Research Center, about gaining understanding of the technological alteration of the modern mind through FMRI.
Dr. Moira Gunn speaks with Dr. Lyle Armstrong, a stem cell researcher and senior lecturer at Newcastle University, who reminds us what stem cell scientists actually do.
Viruses are everywhere, so how do we identify the ones that are problematic? Dr. Moira Gunn speaks with Dr. Joseph DeRisi, professor in biochemistry and biophysics at the University of California, San Francisco, about the promise of an innovative new technology: the virus chip.
Dr. Moira Gunn speaks with Dr. Patrick Gruber, CEO of Gevo and the inventor of plastics derived from corn, about corn derived biofuels. Also, Dr. Bill Gerwick and his graduate student Cameron Coates talk about producing fuel from algae.
Dr. Moira Gunn talks cellulose with Tjerk de Ruiter on a "trade-up" kit for Iowa farmers to cellulosic ethanol, and Thomas Videbaek on a surprising cellulosic ethanol plant in China.
Dr. Moira Gunn speaks with Lori Andrews, the director of the Insititude for Science, Law and Technology in Illinois, about the use of DNA in a court of law.
When President Bush set limits on stem cell research in 2001, millions of families who were hopeful that such research could help alleviate the diseases of their loved ones were devastated. In this Stanford Center for Social Innovation audio lecture, attorney Robert Klein discusses his efforts to author and push through legislation in California which, so far, has succeeded in advancing such research. Sharing personal and political struggles, Klein movingly underscores the urgency behind his quest.
Gaining weight leads to increased risk of becoming a diabetic. Dr. Moira Gunn asks Dr. Christian Weyer, of Amylin Pharmaceuticals, to explain their new combined treatment for diabetes and obesity.